Global Radiopharmaceuticals Market Analysis Report 2022: A $7.2 Billion Market by 2027 – Industry Trends, Share, Size, Growth, Opportunities and Forecasts – ResearchAndMarkets.com

Global Radiopharmaceuticals Market Analysis Report 2022: A $7.2 Billion Market by 2027 – Industry Trends, Share, Size, Growth, Opportunities and Forecasts – ResearchAndMarkets.com




Global Radiopharmaceuticals Market Analysis Report 2022: A $7.2 Billion Market by 2027 – Industry Trends, Share, Size, Growth, Opportunities and Forecasts – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Radiopharmaceuticals Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global radiopharmaceuticals market reached a value of US$ 4.9 Billion in 2021. Looking forward, the market to reach US$ 7.2 Billion by 2027, exhibiting a CAGR of 6.62% during 2021-2027.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Radiopharmaceuticals Market Trends:

The increasing prevalence of cancerous diseases on account of the rising aging population and unhealthy dietary patterns represent the key factors contributing to the growing use of radiopharmaceuticals across the globe. Apart from this, the escalating number of diagnostic centers is also supporting the market.

Moreover, the rising number of oncologists that are suggesting disease-targeted cancer therapy, which utilizes drugs to target specific proteins and genes involved in the development of cancer cells, are positively influencing the overall sales.

Furthermore, the use of radiolabeled peptides and monoclonal antibodies for the diagnosis and treatment of cancerous tumors, along with rising healthcare expenditures, is strengthening the market growth.

Other major factors anticipated to propel the growth of the market include the increasing use of radiopharmaceuticals by oncologists to track radioactivity throughout the body and determine the presence of cancer cells and the increasing shift towards positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) scans.

Key Questions Answered in This Report:

  • How has the global radiopharmaceuticals market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global radiopharmaceuticals market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global radiopharmaceuticals market and who are the key players?
  • What is the degree of competition in the industry?

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

  • Advanced Accelerator Applications (Novartis AG)
  • Bayer AG
  • Bracco S.p.A.
  • Cardinal Health Inc.
  • Curium Pharma
  • General Electric Company
  • IBA RadioPharma Solutions
  • Jubilant Pharma Limited
  • Lantheus Medical Imaging Inc
  • Nordion Inc. (Sotera Health)
  • NTP Radioisotopes SOC Ltd
  • PharmaLogic Holdings Corp.
  • Siemens AG

Key Market Segmentation:

Breakup by Product Type:

  • Diagnostic Nuclear Medicine
  • Therapeutic Nuclear Medicine

Breakup by Application:

  • Oncology
  • Cardiology
  • Neurology
  • Endocrinology
  • Others

Breakup by End Use:

  • Hospitals and Clinics
  • Research Institutes
  • Diagnostic Centers

Breakup by Region:

North America

  • United States
  • Canada

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

Latin America

  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

For more information about this report visit https://www.researchandmarkets.com/r/52w3s3

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900